Assignee
LUPIN LTD
IN·97 granted patents·90 pending applications·142 citations·filing 1999–2024
Top patents by PatentIndex Score
187 records- 0191US11952380B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2022·Granted Apr 9, 2024·3 cites·20 claims
- 0288US9073943B2Antiviral compounds with a dibenzooxaheterocycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·8 cites·22 claims
- 0385US9399638B2Substituted pyridine compounds as CRAC modulatorsLUPIN LTD·Filed 2013·Granted Jul 26, 2016·11 cites·11 claims
- 0483US11278502B2Modified release formulation of lacosamideLUPIN LTD·Filed 2018·Granted Mar 22, 2022·2 cites·24 claims
- 0583US9073942B2Antiviral compounds with a heterotricycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·9 cites·23 claims
- 0681US9598391B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2015·Granted Mar 21, 2017·4 cites·14 claims
- 0779US11459330B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2018·Granted Oct 4, 2022·3 cites·17 claims
- 0879US10556069B2InhalerLUPIN LTD·Filed 2015·Granted Feb 11, 2020·5 cites·10 claims
- 0978US12391695B2PRMT5 inhibitorsLUPIN LTD·Filed 2020·Granted Aug 19, 2025·1 cites·11 claims
- 1078US9163001B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Oct 20, 2015·4 cites·29 claims
- 1177US9555035B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2016·Granted Jan 31, 2017·2 cites·42 claims
- 1277US9393247B2Heteroaryl derivatives as alpha7 nAChR modulatorsLUPIN LTD·Filed 2015·Granted Jul 19, 2016·3 cites·22 claims
- 1377US8383151B2Pharmaceutical compositions of rifaximinLUPIN LTD·Filed 2008·Granted Feb 26, 2013·4 cites·39 claims
- 1477US7763602B2Pyrrole derivatives as antimycobacterial compoundsLUPIN LTD·Filed 2008·Granted Jul 27, 2010·2 cites·24 claims
- 1576US7470786B2Method for manufacture of ceftriaxone sodiumLUPIN LTD·Filed 2006·Granted Dec 30, 2008·4 cites·21 claims
- 1676US2019192490A1Rifaximin ready-to-use suspensionLUPIN LTD·Filed 2018·Application pending·0 cites
- 1776US2025082615A1Solid dispersion of rifaximinLUPIN LTD·Filed 2024·Application pending·0 cites
- 1874US12435066B2Substituted tricyclic compoundsLUPIN LTD·Filed 2020·Granted Oct 7, 2025·1 cites·27 claims
- 1974US7511135B2Method for manufacture of ceftiofurLUPIN LTD·Filed 2003·Granted Mar 31, 2009·9 cites·19 claims
- 2073US10137114B2Rifaximin ready-to-use suspensionLUPIN LTD·Filed 2015·Granted Nov 27, 2018·1 cites·15 claims
- 2173US9428499B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2013·Granted Aug 30, 2016·2 cites·28 claims
- 2272US9931405B2Pharmaceutical compositions for gastrointestinal drug deliveryLUPIN LTD·Filed 2015·Granted Apr 3, 2018·1 cites·12 claims
- 2372US9227919B2Arylalkylamine compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Jan 5, 2016·2 cites·16 claims
- 2471US9359367B2Tetrahydroquinazolinone derivatives as PARP inhibitorsLUPIN LTD·Filed 2013·Granted Jun 7, 2016·3 cites·19 claims
- 2570US7230097B2Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acidLUPIN LTD·Filed 2004·Granted Jun 12, 2007·7 cites·33 claims
- 2669US9737534B2Oxazoline and isoxazoline derivatives as CRAC modulatorsLUPIN LTD·Filed 2015·Granted Aug 22, 2017·1 cites·8 claims
- 2768US10251850B2Process for preparation of cysteamine bitartrateLUPIN LTD·Filed 2018·Granted Apr 9, 2019·1 cites·4 claims
- 2868US9062067B2Process for preparation of darunavir and darunavir ethanolate of fine particle sizeLUPIN LTD·Filed 2013·Granted Jun 23, 2015·1 cites·27 claims
- 2968US7691889B2Antimycobacterial compoundsLUPIN LTD·Filed 2005·Granted Apr 6, 2010·1 cites·16 claims
- 3067US9969691B2Polymorphic forms of pitavastatin sodiumLUPIN LTD·Filed 2015·Granted May 15, 2018·1 cites·7 claims
- 3166US2025034521A1Mammalian cell culture process for recombinant protein productionLUPIN LTD·Filed 2022·Application pending·0 cites
- 3264US10227317B2Process for the preparation of vortioxetineLUPIN LTD·Filed 2016·Granted Mar 12, 2019·1 cites·7 claims
- 3363US9127029B2Process for preparation of substantially pure fosamprenavir calcium and its intermediatesLUPIN LTD·Filed 2014·Granted Sep 8, 2015·0 cites·4 claims
- 3463US2026035451A1Process for manufacturing antibody fragment proteinLUPIN LTD·Filed 2024·Application pending·0 cites
- 3562US7335767B2Method for preparation of ceftiofur and salts thereofLUPIN LTD·Filed 2003·Granted Feb 26, 2008·3 cites·9 claims
- 3662US2024123169A1Breath actuated inhalerLUPIN LTD·Filed 2023·Application pending·0 cites
- 3761US2024350480A1Stable pharmaceutical composition of methylnaltrexone for an oral administrationLUPIN LTD·Filed 2024·Application pending·0 cites
- 3861US2019076536A1Pharmaceutical compositions for gastrointestinal drug deliveryLUPIN LTD·Filed 2018·Application pending·0 cites
- 3961US2020375959A1Solid dispersion of rifaximinLUPIN LTD·Filed 2020·Application pending·0 cites
- 4060USD948704SInhalerLUPIN LTD·Filed 2019·Granted Apr 12, 2022·7 cites·1 claims
- 4159US2008102134A1Controlled release color stable pharmaceutical dosage form of hmg-coa reductase inhibitors, free of alkalizing or buffering agentsLUPIN LTD·Filed 2007·Application pending·0 cites
- 4258US10259790B2Polymorphic forms of pitavastatin sodiumLUPIN LTD·Filed 2018·Granted Apr 16, 2019·0 cites·6 claims
- 4358US9944639B2Quinolizinone derivatives as PI3K inhibitorsLUPIN LTD·Filed 2015·Granted Apr 17, 2018·1 cites·22 claims
- 4458US2009264341A1Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disordersLUPIN LTD·Filed 2009·Application pending·0 cites
- 4558US2008081069A1Novel controlled release formulations of divalproex sodiumLUPIN LTD·Filed 2007·Application pending·0 cites
- 4658US2009270330A1Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disordersLUPIN LTD·Filed 2009·Application pending·0 cites
- 4757USD948703SInhalerLUPIN LTD·Filed 2019·Granted Apr 12, 2022·6 cites·1 claims
- 4857US9573944B2Heterocyclyl compoundsLUPIN LTD·Filed 2013·Granted Feb 21, 2017·0 cites·25 claims
- 4956US10556942B2Process for the purification of TNFR:Fc fusion proteinLUPIN LTD·Filed 2015·Granted Feb 11, 2020·1 cites·20 claims
- 5056US9969731B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2016·Granted May 15, 2018·0 cites·17 claims
Showing the top 50 of 187 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when LUPIN LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →